- Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs2017 | Second Faculty of Medicine
- Primary cillia and their biological functions2011 | Faculty of Medicine in Hradec Králové
- Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Gastrointestinal stromal tumor (GIST): advances in 20132014 | Faculty of Medicine in Pilsen
- Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy2011 | Second Faculty of Medicine
- Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease2012 | First Faculty of Medicine
- Advances in the treatment of gastrointestinal stromal tumor2007 | Publication without faculty affiliation
- Sunitinib - new clinical studies2007 | Publication without faculty affiliation
- Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome2020 | Faculty of Medicine in Pilsen
- Komentář ke studii: Účinnost a bezpečnost regorafenibu v léčbě pokročilého GIST po selhání imatinibu a sunitinibu - metaanalýza2018 | Publication without faculty affiliation
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
- Antiangiogenic therapy of lung cancer2018 | Second Faculty of Medicine
- In Vivo Modulation of Angiogenic Gene Expression by Acyclic Nucleoside Phosphonates PMEDAP and PMEG2009 | First Faculty of Medicine
- Gastrointestinal stromal tumour: advances in treatment2020 | Publication without faculty affiliation
- Regorafenib - role of the drug in the current real-life oncological practice2018 | Publication without faculty affiliation
- Nintedanib2016 | First Faculty of Medicine
- Olaratumab in clinical trials2018 | Publication without faculty affiliation
- Komentář ke studii (Nintedanib v léčbě idiopatické plicní fibrózy - analýza výsledků studií II. a III. fáze)2016 | First Faculty of Medicine
- Regorafenib - the position of this drug in a current daily oncologic practice2019 | Publication without faculty affiliation
- Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer2019 | First Faculty of Medicine
- Signaling Involved in Hair Follicle Morphogenesis and Development2014 | Faculty of Medicine in Hradec Králové
- Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes2012 | First Faculty of Medicine
- Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative2017 | First Faculty of Medicine